Marex Group (MRX) adopts F‑3 shelf after redomiciliation; New Marex succeeds as issuer
Marex Group Limited has filed a post-effective amendment to its Form F-3 shelf prospectus, reflecting the succession of New Marex as issuer after a corporate reorganization and redomiciliation to Bermuda in July 2026. The amendment confirms New Marex assumes Old Marex's obligations under existing SEC-registered indentures and notes for debt securities. The prospectus covers future offerings of various debt securities and incorporates recent financial developments.
Marex Group (MRX) may sell senior unsecured index‑linked notes
Marex Group (MRX) has filed a prospectus for the potential sale of senior unsecured debt obligations, or "Notes," linked to various reference assets such as equity indices. These Notes will be direct, senior, unsecured obligations of Marex and will rank equally with other senior unsecured indebtedness, but they are not bank deposits or government-insured. The prospectus highlights various risks, including credit risk and potential conflicts of interest related to Marex's hedging activities, and notes that the specific terms of each offering will be detailed in a separate pricing supplement.
How Marex’s Shift to Bermuda and Russell 2000 Exit At Marex Group (MRX) Has Changed Its Investment Story
Marex Group plc recently completed its redomiciliation to Bermuda, effective July 1, 2026, aiming to simplify its structure and reduce operating costs while aligning with its Nasdaq listing. This move, along with its removal from Russell 2000 indices, will reshape its investment narrative, though not immediately impacting its core business drivers. The company's future hinges on its ability to compound earnings despite competitive pressures and managing regulatory burdens and integration of past deals.
How Marex’s Shift to Bermuda and Russell 2000 Exit At Marex Group (MRX) Has Changed Its Investment Story
Marex Group plc has redomiciled from England and Wales to Bermuda, effective July 1, 2026, aligning its corporate law with its Nasdaq listing and aiming for structural simplification and cost reduction. This move, along with its removal from Russell 2000 indices, is expected to reshape its investment narrative, though the core drivers of its business remain execution in prime services and integration of past deals. The article suggests investors should consider the implications of Bermuda's US-style corporate law and rising regulatory burdens.
Marex redomiciliation to Bermuda: Scheme becomes effective
Marex Group Limited has completed its redomiciliation from England and Wales to Bermuda, effective July 1, 2026. This strategic move, approved by shareholders and regulatory bodies, aims to simplify the company's corporate structure, streamline its regulatory framework, and achieve cost savings. The redomiciliation aligns Marex with the US-style corporate law prevalent in Bermuda, which is beneficial given its Nasdaq listing.
Marex Group plc (MRX) Receives a Buy from Goldman Sachs
Goldman Sachs analyst Alexander Blostein maintained a Buy rating on Marex Group plc (MRX) with a price target of $62.00. Blostein, a 5-star analyst, has an average return of 16.5% and covers the Financial sector. Marex Group plc reported strong quarterly results with a revenue of $3.13 billion and a net profit of $231.5 million.
Marex Group Limited (MRX) shifts holding company to Bermuda and maintains Nasdaq listing
Marex Group Limited (MRX) has successfully completed its redomiciliation, moving its holding company from the UK to Bermuda. This strategic move aims to rationalize the corporate structure, deliver cost savings, and align with US-style corporate law, matching its Nasdaq listing. Shareholders received new Marex ordinary shares on a one-for-one basis, maintaining economic ownership and continuous trading under the "MRX" ticker.
Marex Group Limited Completes Redomiciliation to Bermuda
Marex Group Limited has finalized its redomiciliation from England and Wales to Bermuda, effective July 1, 2026. This move, approved by shareholders and regulators, aims to simplify Marex's corporate structure, enhance operational efficiency, and better align it with NASDAQ listing requirements. CEO Ian Lowitt anticipates the transition will result in cost savings and improved operations due to the company's significant growth and acquisitions.
Marex moves corporate base to Bermuda after court-sanctioned scheme
Marex (NASDAQ: MRX) has successfully completed its redomiciliation from England and Wales to Bermuda, effective July 1, 2026, at 08:41 AM London time. This strategic move, sanctioned by the English High Court and approved by shareholders on May 21, 2026, aims to streamline its corporate structure, regulatory framework, and achieve cost efficiencies. The change aligns Marex with Bermuda's US-style corporate law, complementing its Nasdaq listing.
Marex redomiciliation to Bermuda: Scheme becomes effective
Marex Group Limited has successfully completed its redomiciliation to Bermuda from England and Wales, effective July 1, 2026. This strategic move aims to rationalize the corporate structure and regulatory framework, deliver cost savings, and align with a U.S.-style corporate law following its Nasdaq listing. The decision followed shareholder approval, global regulatory clearances, and sanction by the English High Court.
Marex redomiciliation to Bermuda: Scheme becomes effective
Marex Group plc has successfully completed its redomiciliation to Bermuda from England and Wales, effective July 1, 2026. This move, approved by shareholders and the English High Court, aims to rationalize the company's corporate structure, streamline its regulatory framework, and achieve cost savings by aligning with US-style corporate law given its Nasdaq listing.
Marex Group plc Ordinary Shares (NASDAQ:MRX) Receives Average Rating of "Buy" from Analysts
Marex Group plc Ordinary Shares (NASDAQ:MRX) has received a consensus "Buy" rating from six analysts, with an average 1-year price target of $63.75. The company recently reported solid earnings of $1.48 EPS and a 1.1% dividend yield, despite a recent 8.2% drop in stock price. Several firms, including Zacks Research, UBS, and TD Cowen, have issued positive reports and raised their price targets for MRX.
Securities Class Action Lawsuit Filed Against Marex Group plc (MRX) – Levi & Korsinsky Represents Shareholders
A securities class action lawsuit has been filed against Marex Group plc (MRX) by Levi & Korsinsky, LLP, representing shareholders who suffered losses between May 16, 2024, and August 5, 2025. The lawsuit alleges that Marex Group plc inflated its cash flow and the revenues, assets, and profits of its Market Making segment through undisclosed intercompany transactions. Shareholders are encouraged to contact Levi & Korsinsky to learn about their rights to participate in the recovery effort.
Levi & Korsinsky Urges Marex Group plc (MRX) Shareholders to Act Before Lead Plaintiff Deadline December 8, 2025
Levi & Korsinsky is urging Marex Group plc (NASDAQ:MRX) shareholders who suffered losses between May 16, 2024, and August 5, 2025, to act before the lead plaintiff deadline of December 8, 2025. A class action lawsuit alleges that Marex improperly inflated its cash flow, revenues, assets, and profits of its Market Making segment through off-book intercompany transactions, misleading investors. Shareholders are encouraged to contact Levi & Korsinsky to learn about their rights to potentially recover losses.
Enterprise value to EBITDA forward of Marex Group plc – NASDAQ:MRX
This article provides access to the enterprise value to EBITDA forward data for Marex Group plc (NASDAQ: MRX). It is a finance-related data point available on TradingView, indicating the company's valuation metric for investors and analysts. The content focuses on directing users to this specific financial data for MRX.
Price to earnings forward of Marex Group plc – NASDAQ:MRX
This article provides access to the forward price-to-earnings ratio for Marex Group plc (NASDAQ: MRX). It is a financial data point available on TradingView, indicating market data and tools provided by various financial services.
Marex Group (MRX) sets July 1 effective date for Bermuda redomiciliation
Marex Group plc has received High Court approval for its redomiciliation plan, moving its parent holding company to Bermuda as Marex Group Limited. This follows shareholder approval on May 21, 2026, and is expected to become effective on July 1, 2026. Existing Marex shares will be cancelled and replaced on a one-for-one basis with shares in the new Bermuda entity, which will continue trading on Nasdaq under the MRX ticker.
Price to book forward of Marex Group plc – NASDAQ:MRX
This article provides access to the "Price to book forward" financial metric for Marex Group plc (NASDAQ: MRX) on TradingView. It highlights that the market was closed and no trades were recorded at the time of the information display. The page is part of the extensive financial data provided by TradingView for various markets and assets.
Marex Group plc Actuals & Estimates (NASDAQ:MRX)
This article provides an overview of Marex Group plc (NASDAQ: MRX) stock, including its current price, market capitalization, and historical performance. It also details financial estimates, actual earnings, revenue, and dividend information, sourced from analyst forecasts and company reports. The article addresses frequently asked questions about MRX, such as future price predictions and volatility.
MRX Forecast — Price Target — Prediction for 2027
This article provides a forecast for Marex Group plc (MRX) stock, including analyst price targets, historical performance data, and financial metrics. Seven analysts estimate a one-year price target, with a maximum of $75.00 and a minimum of $55.00. The article also covers past earnings, revenue, dividends, and market capitalization, along with a "buy" signal from current technical analysis.
Marex Group PLC (MRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Marex Group PLC (MRX), focusing on its stock performance, indicator signals, and moving averages. According to the analysis, the overall signal based on moving averages and other technical indicators is "Buy", with 6 buy signals and 0 sell signals from moving averages MA5 to MA200, and a mixed signal from other indicators. The report also defines technical ratings and moving averages, and addresses frequently asked questions about the stock's technical status.
Marex Group (MRX) Stock Could Be 14% Overvalued After Board Appointment
Marex Group (MRX) has appointed Georges Assi to its Group Board and Risk Committee, a move that highlights the company's focus on credit and fixed income expertise. Despite strong recent share price performance, Simply Wall St suggests the stock might be 14% overvalued, with a fair value estimated at $57.13 compared to its current trading price of $64.85. The article advises investors to consider the company's reliance on acquisitions and commodity market exposure when evaluating its efficiency narrative.
Marex Group (MRX) prices $8.5M contingent-income barrier notes due Dec 2027
Marex Group plc has priced an $8.5 million offering of Issuer Callable Contingent Income Barrier Notes, maturing on December 22, 2027. These notes are linked to the performance of three underlying assets: the Invesco S&P 500 Equal Weight ETF, the Russell 2000 Index, and the Nasdaq-100 Index. Investors could receive quarterly contingent coupons of 3.413% if each underlying meets its specified trigger, but face potential loss of principal if the worst-performing underlying falls below its barrier value.
Marex Group (MRX) launches $1.08M callable barrier notes — 13.75% YTM
Marex Group (MRX) has launched $1.08 million in callable fixed interest barrier notes, offering a 13.75% annualized yield. These notes are linked to the performance of the S&P 500, Russell 2000, and Nasdaq-100 indices, with quarterly interest payments of $34.38 per $1,000 principal. Investors face the risk of up to 100% loss of principal if a "Trigger Event" occurs and the worst-performing underlying index falls below its initial value.
Precision Trading with Marex Group Plc (MRX) Risk Zones
This article from Stock Traders Daily discusses predictive AI analysis for Marex Group Plc (MRX), identifying risk zones and potential trading strategies. It highlights a near-term neutral sentiment amidst mid and long-term strength, with no resistance levels currently above the price, suggesting upside potential. The analysis provides specific entry, target, and stop-loss zones for position trading, momentum breakout, and risk hedging strategies.
13.752% annual yield Marex notes (MRX) callable June 2027 – structured product
Marex Group plc is offering Issuer Callable Fixed Interest Barrier Notes linked to the S&P 500, Russell 2000, and Nasdaq-100, maturing June 29, 2027. These notes offer a 13.752% annual yield, payable quarterly, and are callable by Marex starting September 22, 2026. Investors face potential principal loss if a Trigger Event occurs and the worst-performing underlying index falls below its initial value, exposing them to full downside risk.
Marex Group plc (MRX) launches callable barrier notes, high contingent yield
Marex Group plc (MRX) has launched Issuer Callable Contingent Income Barrier Notes linked to the Invesco S&P 500® Equal Weight ETF (RSP), Russell 2000® Index (RTY), and Nasdaq-100 Index® (NDX). These notes offer a quarterly contingent coupon of 3.413% (13.652% p.a.) if each underlying is at or above 70% of its initial value. Investors face full downside exposure if not redeemed early and the worst-performing underlying finishes below 65% of its initial value, potentially losing up to 100% of the principal, with payments subject to Marex’s credit risk.
Marex Group PLC stock hits all-time high at 63.9 USD
Marex Group PLC's stock reached an all-time high of $63.90, reflecting a 59.76% increase over the past year and strong investor confidence. InvestingPro analysis suggests the company is undervalued, holding a "GREAT" financial health rating. This milestone follows recent significant corporate developments including successful bond offerings, bondholder consent for indenture amendments, and handling a substantial portion of CME's 24/7 trading contracts.
Marex Group schedules court hearing on proposed redomiciliation to Bermuda
Marex Group announced a court hearing on June 26, 2026, for its proposed redomiciliation from the UK to Bermuda, seeking sanction for a scheme of arrangement with shareholders. If approved, the redomiciliation is expected to become effective on July 1, 2026, leading to the substitution of its Nasdaq-listed shares with those of a Bermuda-incorporated entity. The company emphasized that this move is subject to court approval and other conditions.
Marex Group (NASDAQ: MRX) sets UK court hearing for Bermuda move
Marex Group (NASDAQ: MRX) has scheduled a UK High Court hearing for June 26, 2026, to approve its scheme of arrangement for redomiciliation to Bermuda. If sanctioned, the move is expected to become effective on July 1, 2026, resulting in the substitution of existing Nasdaq-listed ordinary shares with those of the new Bermuda-domiciled entity, Marex Group Limited. The company emphasizes that these timings are forward-looking and subject to various risks and uncertainties.
Marex Group PLC stock hits all-time high at 63.9 USD
Marex Group PLC's stock reached an all-time high of $63.90, marking significant growth with a 59.76% increase over the past year. InvestingPro analysis suggests the company is undervalued, rating its financial health as "GREAT." This surge follows major corporate developments, including a $500 million perpetual subordinated resettable fixed rate notes offering and a $500 million senior notes offering, alongside a planned redomiciliation to Bermuda in July 2026.
HIFI, DRW, and Marex Advance Onchain Repo on the Canton Network
HIFI, DRW, and Marex successfully completed an onchain repurchase transaction on the Canton Network, marking a significant advancement for tokenized capital markets. The transaction involved HIFI providing cash against U.S. Treasuries from DRW, with Marex acting as prime broker, utilizing competitive price discovery and real-time, atomic settlement. This initiative demonstrates the potential for blockchain technology to enhance efficiency, reduce settlement risk, and enable 24/7 operations in the multi-trillion dollar repo market.
HIFI, DRW and Marex settle repo onchain in real time
HIFI, DRW, and Marex successfully completed an onchain repurchase (repo) transaction on the Canton Network, with Marex acting as prime broker. This trade utilized Tradeweb RFQ for competitive price discovery and achieved real-time, atomic settlement, converting fiat cash into USDC and USDCx while maintaining confidentiality. The initiative highlights the potential for onchain repo to enable continuous collateral and cash mobility, support 24/7 markets, and offer significant benefits to non-U.S. institutions holding dollars and U.S. Treasuries, given the U.S. repo market’s $12.6 trillion daily exposures and the strong industry interest in repo tokenization.
Insider Sell Alert: Paolo Tonucci Sells Shares of Marex Group PL
Paolo Tonucci, holding a position at Marex Group PLC, sold 16,666 shares on June 15, 2026, and now owns 1,298,943 shares. This transaction is part of a trend over the past year where Tonucci has sold a total of 50,000 shares with no purchases, and the company has seen nine insider sales and no purchases. Marex Group PLC shares were trading at $62.45 with a market cap of $4.42 billion and a P/E ratio of 13.60, which is below the industry median but above its historical median.
Insider sale at Marex Group (MRX): officer sells 16,666 shares under 10b5-1 plan
Marex Group officer Paolo Tonucci sold 16,666 Ordinary Shares of the company on June 15, 2026, for approximately $1.04 million. These sales were executed under a pre-arranged Rule 10b5-1 trading plan established in October 2025, indicating they were scheduled and not opportunistic. Tonucci still holds a significant amount of equity, including 220,746 shares tied to deferred bonus plan awards, suggesting the transaction is a routine liquidity event rather than a change in investment thesis.
Marex Group (MRX) CEO sells 37,143 shares under Rule 10b5-1 plan
Marex Group CEO Ian T. Lowitt sold 37,143 Ordinary Shares on June 12, 2026, under a pre-arranged Rule 10b5-1 plan. The shares were sold at weighted average prices in the low-$60s per share. Following these transactions, Lowitt directly holds 2,831,358 Ordinary Shares, which includes 194,411 shares underlying deferred bonus plan awards.
Does Marex Group (MRX) Board Shift Hint at a Deeper Rethink of Its Risk Engine?
Marex Group recently appointed fintech entrepreneur and private credit specialist Georges Assi to its Group Board and Risk Committee, a move that could significantly influence its risk outlook. This appointment is particularly relevant given Marex's reliance on risk management across various markets. While Marex's investment narrative emphasizes its role in volatile markets, the board shift suggests a potential deeper re-evaluation of its risk engine and how it evaluates balance sheet, counterparty, and product risks, especially as the firm continues to grow through acquisitions.
MRX (MRX) affiliate Paolo Tonucci reports several 2026 Common Stock sales
An affiliate of Marex Group plc (MRX), Paolo Tonucci, filed a Form 144 notice detailing proposed and recent sales of Common Stock. The filing lists multiple transactions in early 2026, including sales of 16,666 to 16,668 shares on specific dates, with reported gross proceeds. These transactions involve restricted securities acquired in private transactions, and Form 144 serves as a regulatory disclosure of these dispositions rather than indicating issuer proceeds.
Marex Group (NasdaqGS:MRX) Stock After Oversubscribed US$500m Note Offering Is The Valuation Justified
Marex Group (NasdaqGS:MRX) recently completed an oversubscribed US$500 million perpetual subordinated note issue, drawing renewed investor attention. Despite a slight daily pullback, the stock shows strong momentum with significant returns over the past 7, 90, and 365 days. While a popular narrative suggests the stock is 8.5% overvalued compared to a fair value of $57.13, the company's investments in technology promise future margin expansion, but potential risks like acquisition or compliance costs could impact this valuation.
Marex (MRX) sells $300K autocallable notes; 12% annual coupon
Marex Group plc is offering $300,000 in Autocallable Fixed Income Notes with a 12% annual coupon, linked to the performance of Apple (AAPL), Coherent (COHR), and Morgan Stanley (MS) stocks. These notes provide quarterly fixed interest payments of $30 per $1,000 principal amount and can be automatically called if underlying stocks meet certain thresholds. Investors face leveraged downside exposure if the worst-performing stock falls beyond a 50% buffer, potentially leading to a loss of up to 100% of the principal at maturity.
MRX (Nasdaq) Form 144: Director/issuer to sell 29,769 and 7,374 shares via JP Morgan
A Form 144 filing by Marex Group plc (MRX) indicates proposed sales of common stock by an issuer insider through J.P. Morgan Securities LLC. The filing details two proposed sales tied to compensation grants: 29,769 shares from a 03/10/2025 grant and 7,374 shares from a 05/19/2025 grant. This notice outlines planned dispositions under Rule 144, with settlement details and actual sale amounts to be disclosed in future filings.
Marex Group (MRX) offers autocallable notes paying 12.00% per annum, buffer 50%
Marex Group plc is offering Autocallable Fixed Income Notes linked to the performance of Apple (AAPL), Coherent Corp. (COHR), and Morgan Stanley (MS), with a 12.00% per annum interest rate payable quarterly. These notes feature a 50% buffer and a 200% downside leverage factor, meaning investors are protected against losses up to 50% of the worst-performing underlying but face amplified losses beyond that threshold. The notes are subject to automatic call if all underlying assets meet a certain threshold, and payments at maturity depend on the worst-performing underlying's reference return.
Marex Group (MRX) director receives 2,070-share equity award
Marex Group plc director Linda Kristine Myers was granted 2,070 restricted share awards on June 9, 2026, at no cash cost. This transaction, categorized as routine share-based compensation, increased her direct holdings to 23,214 Ordinary Shares. The awards represent contingent rights to ordinary shares upon vesting, not an open-market purchase.
Marex Group (MRX) director receives 2,070 restricted share awards
Marex Group plc director Ing Sarah was granted 2,070 restricted share awards, which are contingent rights to receive ordinary shares upon vesting. Following this compensation-related transaction, Ing Sarah directly holds 10,895 ordinary shares and indirectly holds 535 shares through a spouse. The filing clarifies that this was a grant, not an open-market purchase or sale.
Marex Group (MRX) director gets 2,070 restricted shares grant
A director at Marex Group plc (MRX), Schweinitz Konstantin Graf von, was granted 2,070 restricted share awards. Each award is a contingent right to one ordinary share upon vesting and settlement, bringing his direct holdings to 26,165 ordinary shares. The transaction price for these awards was $0.00 per share, indicating an equity grant rather than a market purchase.
Marex Group plc (MRX) director receives 2,070 restricted Ordinary Shares grant
Marex Group plc director Assi Georges was granted 2,070 restricted Ordinary Shares on June 9, 2026, as equity compensation. These shares were awarded at a price of $0.00 each and are contingent rights that will convert into ordinary shares upon vesting and settlement, meaning it was not an open-market purchase. Following this grant, Assi Georges directly holds 2,070 shares in the company.
XS2487831765 Bond Price and Chart — VIE:XS2487831765
This article provides details on the XS2487831765 bond, issued by Marex Group plc with a 13.008% interest rate and maturing on May 29, 2026. The bond is listed on the Vienna Stock Exchange, and the market is currently closed with no trades. Users are prompted to sign up to access advanced bond data, including coupon rates, redemption details, and risk assessments.
Marex Raises $500 Million in Hybrid Notes to Refinance Capital and Fund Acquisitions
Marex Group plc successfully raised $500 million through an offering of perpetual subordinated resettable fixed rate hybrid notes. The proceeds will be used for general corporate purposes, including repurchasing existing high-coupon convertible notes and funding future acquisitions. This move is expected to enhance Marex's capital position and flexibility for growth, with the new notes receiving full equity credit from S&P and significantly lower funding costs compared to previous issuances.
Marex Group PLC Announces Closing Of U.S.$500 Million Hybrid Notes
Marex Group PLC has announced the successful closing of its U.S.$500 million hybrid notes offering. The news, distributed by Refinitiv/Reuters, indicates a significant financial event for the company, though further details regarding the terms or purpose of the notes are not provided in this brief announcement.
Marex Group completes offering of $500M hybrid notes
Marex Group plc successfully completed a $500 million offering of perpetual subordinated resettable fixed rate notes, achieving significantly lower pricing at 7.7% compared to its previous issuance. The net proceeds are intended for general corporate purposes, including a tender offer for existing notes and funding acquisitions. CEO Ian Lowitt highlighted the strong oversubscription and confidence from investors, attributing part of this success to the company's Bermuda redomiciliation plans.
